CASP1 and stroke disorder: Hyperglycemia induces superimposed effects on caspase-1 in stroke, as specific NLRP3 inhibitor MCC950 showed stronger alleviation of BBB destructions in hyperglycemic stroke than stroke without hyperglycemia (Hong et al., 2018).